Why the study?
Does the advanced immunoassay for cardiac troponin I on the AxSYM platform improve analytical sensitivity compared to the old method and the Access system?
Does the advanced immunoassay for cardiac troponin I on the AxSYM platform improve analytical sensitivity compared to the old method and the Access system?
The advanced AxSYM Troponin-I immunoassay provides improved analytical sensitivity over the older method, yielding clinical results comparable to the Access system.
No takes yet. Share an insight, caveat, or question.
May enable lower troponin detection on AxSYM; leaves open effects on clinical decisions or outcomes.
Storti et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: